Vaccination in Pregnancy against Pertussis: A Consensus Statement on Behalf of the Global Pertussis Initiative

Bahaa Abu-Raya1,2, Kevin Forsyth3, Scott A Halperin4

  • 1BC Children's Hospital Research Institute, Vancouver, BC V5Z 4H4, Canada.

Vaccines
|December 23, 2022
PubMed

Insights

Vaccinating pregnant individuals against pertussis (whooping cough) is the best way to protect newborns. This strategy shields infants during their most vulnerable early months from severe illness and death.

Area of Science:

  • Immunology
  • Maternal and Child Health
  • Vaccinology

Background:

  • Infants face significant risks of severe illness and death from pertussis (whooping cough) in early life.
  • Maternal immunization during pregnancy is a key strategy to provide passive immunity to newborns.
  • Pertussis vaccination in pregnancy aims to protect infants before they can be directly immunized.

Purpose of the Study:

  • To review and synthesize current scientific evidence on the safety and efficacy of pertussis vaccination during pregnancy.
  • To address outstanding scientific questions and provide consensus statements on this vaccination strategy.
  • To inform public health recommendations and clinical practice regarding maternal pertussis immunization.

Main Methods:

  • A comprehensive review of existing and historical scientific literature on pertussis vaccination in pregnancy.
  • Convening a meeting of the Global Pertussis Initiative to discuss and evaluate the evidence.
  • Formulating consensus statements based on the reviewed literature and expert discussion.

Main Results:

  • The review supports vaccination against pertussis in pregnancy as an effective method for infant protection.
  • Key scientific literature confirms the benefits of maternal immunization for reducing infant pertussis.
  • Consensus statements were developed addressing current evidence and knowledge gaps.

Conclusions:

  • Vaccination against pertussis in pregnancy is a critical public health intervention.
  • This strategy provides essential protection for infants against severe pertussis during their first months of life.
  • Continued research and monitoring are important to optimize maternal immunization programs.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
45.1K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.6K
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by...
381
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.3K
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
27
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.3K